ULURU Inc. is an emerging specialty pharmaceutical company focused on the development of a portfolio of wound management, plastic surgery and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative transmucosal delivery system and Hydrogel Nanoparticle Aggregate technology.

• Streaming Audios
• About Us
• News
• Stock Information
• SEC Documents
  • 10-K Annual Reports
  • 10-Q Quarterly Reports
  • Section 16 Filings
  • All SEC Filings
• Transfer Agent Information
  • Continental Stock & Trust Co
    17 Battery Place
    New York, NY 10004-1123
    Tel: 212-845-3212
    Fax: 212-616-7616
    Web: http://www.continentalstock.com
• Corporate Governance
  • Leadership Team
  • Independent Auditors
    • Lane Gorman Trubitt, L.L.P.
      2626 Howell Street, Suite 700
      Dallas, Texas 75204-4064
      Tel: 214-871-7500
      Fax: 214-871-0011
  • Audit Committee Charter
  • Compensation Committee Charter
  • Nominating and Corporate Governance Committee Charter
  • Code of Ethics
  • "Whistleblower" Policy
• Request a Kit
• Contact Information

Adobe® Reader® is required to view certain Corporate Governance information, and can be downloaded for free by clicking here.